Abbott Laboratories (ABT) Total Liabilities (2009 - 2026)

Abbott Laboratories' Total Liabilities history runs 18 years deep, the most recent figure standing at $57.7 billion for Q1 2026.

• In Q1 2026, Total Liabilities fell 29.62% year-over-year to $57.7 billion; the TTM figure through Mar 2026 stood at $57.7 billion (down 29.62% YoY), while the FY2025 annual figure was $34.6 billion, down 38.53% from the prior year.
• Total Liabilities came in at $57.7 billion for Q1 2026 at Abbott Laboratories, up from $34.6 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $82.9 billion in Q2 2022 to a low of -$32.4 billion in Q4 2022.
• A 5-year average of $54.4 billion and a median of $56.3 billion in 2024 frame the typical range for Total Liabilities.
• Across the five-year window, Total Liabilities plunged 88.12% in 2022 and soared 249.33% in 2023, its largest moves.
• Abbott Laboratories' Total Liabilities stood at -$32.4 billion in 2022, then jumped by 249.33% to $48.3 billion in 2023, then rose by 16.37% to $56.3 billion in 2024, then tumbled by 38.53% to $34.6 billion in 2025, then surged by 66.93% to $57.7 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $57.7 billion, $34.6 billion, and $33.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison